MarketersMEDIA / Newsroom / Molecular Diagnostics Market Boon for Advanced Healthcare R&D

Molecular Diagnostics Market Boon for Advanced Healthcare R&D

Share This Press Release

The global molecular diagnostics market size to be around $16.54 billion to $17.44 billion as of 2018. The market is growing at a positive CAGR of around 4.5% to 4.8% through the forecast period of 2019 to 2025.

— Global Molecular Diagnostics Market: Demand Analysis and Growth Forecast

Globally, cases of infectious diseases such as hepatitis, HIV, chlamydia, and others have increased in the previous decade. The consequence of such fatal diseases has increased the demands for advanced molecular diagnostic techniques in the healthcare industry. According to the National Centre for Biometrics Information (NCBI), over 200 million surgical operations are performed annually on the global scale; and despite strong awareness level, around 4,000 surgical errors occur in the United States each year. This inaccuracy has resulted in vast rates of mortality, which can be prevented by the employment of optimistic molecular diagnostic techniques.

The gathered information resonates with the business analysis report from IndustryARC that concluded the global molecular diagnostics market size to be around $16.54 billion to $17.44 billion as of 2018. The market is growing at a positive CAGR of around 4.5% to 4.8% through the forecast period of 2019 to 2025. The molecular diagnostic market is growing because of the fact that diagnostic errors exist and are responsible for a significant number of deaths. This report covers molecular diagnostics Market Size by type and applications, molecular diagnostics market share by top 5 companies and also the market share by start-ups during the forecast period.

Molecular diagnostics is a pool of techniques used to analyze biological markers in the individual’s genetic code and determine the reaction of proteins by applying molecular biology to medical testing. These tests are accessed on a range of medical issues such as pharmacogenomics, human leucocyte antigen typing, oncology, and coagulation.

View Full Table Of Content Of Molecular Diagnostics Market
https://www.industryarc.com/Report/10604/molecular-diagnostics-market.html

Global Molecular Diagnostics Market: Leading Segments

The maximum demands for the molecular diagnostics market are emerging in the North America. The region produced around 34% to 37% of the total demand share in the molecular diagnostics marketplace in 2018. The large market share is justified since the region encapsulates prominent portion of increased chronic, cardiovascular, cancer, and infectious disease as well as robust healthcare infrastructure.

Infectious disease is the dominant application segment of the global molecular diagnostics market, with an impressive CAGR of 12% to 15% during the aforementioned forecast period. According to the Centers for Disease Control (CDC), around 1.7 million infections are recorded annually which approximately leads to 99,000 deaths each year. So, an advanced molecular diagnostic system is presumed to optimize the monitoring conditions and reduce infections on a global level.

Global Molecular Diagnostics Market Trends

The recent decade marked the advancements in the instrumentations and chemistry including integration, automation, ability, and its output to use the instrumentation in a random-access mode. Regular investments and funding in the R&D department of the diagnostic sector of the healthcare industry will lead to significant profits in the global molecular diagnostics market.

Emerging advance IoT and machine learning based sensors in the healthcare industry are expected to change the diagnostics landscape. Integrating cognitive sensors will project the medical data at a precise level which will improve monitoring in the global molecular diagnostics market.

Talk to one of our sales representative about the full report by providing your details in the link below:
https://www.industryarc.com/support.php?id=10604

Global Molecular Diagnostics Market: Competitive Landscape
Some of the key companies identified in the report that are currently holding majority shares in the global molecular diagnostics market are: Roche, Hologic, QIAGEN, Abbott Laboratories, and Danaher Corporation.

Related Reports:

A. Oncology Based Molecular Diagnostics Market
https://www.industryarc.com/Research/Oncology-Based-Molecular-Diagnostics-Market-Research-503856

B. Point of Care Molecular Diagnostics Market
https://www.industryarc.com/Research/Point-Of-Care-Molecular-Diagnostics-Market-Research-501378

Media Contact:
Mr. Venkat Reddy
Sales Manager
Email: sales@industryarc.com
Contact Sales: +1-614-588-8538

About IndustryARC:

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

Contact Info:
Name: Venkat Reddy
Email: Send Email
Organization: IndustryARC
Phone: +1-614-588-8538
Website: https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html

Source URL: https://marketersmedia.com/molecular-diagnostics-market-boon-for-advanced-healthcare-rd/88911614

Source: MarketersMedia

Release ID: 88911614

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2019 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).